CG-P received research funding from Pfizer Inc

CG-P received research funding from Pfizer Inc. change; any change in grade represents a new event. cConcurrent medications used for management of ALT and/or AST elevations included essential phospholipids, ursodiol, steroids, S-adenosylmethionine, milk thistle extract, and glycyrrhizic acid. Patients may have received 1 medication. dTwo patients received transfusion(s) and 33 patients received growth factor(s). ePatients …